open access

Vol 56, No 6 (2005)
Review article
Published online: 2006-06-26
Submitted: 2013-02-15
Get Citation

Markers of malignancy in pheochromocytomas

Stanisław Sporny, Jacek Musiał
Endokrynologia Polska 2005;56(6):946-951.

open access

Vol 56, No 6 (2005)
Review article
Published online: 2006-06-26
Submitted: 2013-02-15

Abstract

A pheochromocytoma is a neoplasm composed of cells which synthesize and release catecholamines. These tumors produce the hypertension which can be cured with surgical excision of the lesion. The pathological picture of pheochromocytomas is varied and nothing but the presence of metastases can determine aggressiveness of this neoplasm. Current studies try to look for other biological markers which can separate malignant tumors before they metastasize. It allows to target with more effective therapy. Many studies analyze details of microscopic features of these tumors, immunohistochemical markers and molecular disorders. It seems that the most important factor in estimation of aggressiveness of pheochromocytomas is PASS scale. The detection of high expression of telomerase and hTERT and high proliferative activity, measured by immunohistochemistry with the MIB-1 antibody supports most strongly biological malignancy of pheochromocytoma.

Abstract

A pheochromocytoma is a neoplasm composed of cells which synthesize and release catecholamines. These tumors produce the hypertension which can be cured with surgical excision of the lesion. The pathological picture of pheochromocytomas is varied and nothing but the presence of metastases can determine aggressiveness of this neoplasm. Current studies try to look for other biological markers which can separate malignant tumors before they metastasize. It allows to target with more effective therapy. Many studies analyze details of microscopic features of these tumors, immunohistochemical markers and molecular disorders. It seems that the most important factor in estimation of aggressiveness of pheochromocytomas is PASS scale. The detection of high expression of telomerase and hTERT and high proliferative activity, measured by immunohistochemistry with the MIB-1 antibody supports most strongly biological malignancy of pheochromocytoma.
Get Citation

Keywords

pheochromocytoma; PASS; proliferative activity; immunohistochemistry

About this article
Title

Markers of malignancy in pheochromocytomas

Journal

Endokrynologia Polska

Issue

Vol 56, No 6 (2005)

Pages

946-951

Published online

2006-06-26

Bibliographic record

Endokrynologia Polska 2005;56(6):946-951.

Keywords

pheochromocytoma
PASS
proliferative activity
immunohistochemistry

Authors

Stanisław Sporny
Jacek Musiał

Important: This website uses cookies.tanya dokter More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

Via MedicaWydawcą serwisu jest  "Via Medica sp. z o.o." sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail:  viamedica@viamedica.pl